Friday, May 30, 2014

Vitamin E and Alzheimer's, Part 2

A group of 613 patients with mild to moderate Alzheimer’s disease were in the study related to Alzheimer’s and aolpha tocepherol (fat-soluble Vitamin E and antioxidant) , which was launched in August 2007 and finished in September 2012 at 14 Veterans Affairs Medical Centers. They examined the effects of Vitamin E, 2,000 IU/day. Kenneth Davis, MD, Chief Executive Officer and President of the Mount Sinai Health System indicated that this study is the first to show an added benefit for Vitamin E in mild-to-moderate disease.” He said, “Now that we have a strong clinical trial showing that vitamin E slows functional decline and reduces the burdens on caregivers, Vitamin E should be offered to patients with mild-to-moderate Alzheimer’s disease.” [Mary Sano, PhD, trial co-investigator, also led a study on Vitamin E in patients with moderately severe Alzheimer’s disease and found that the vitamin slowed disease progression in this group of patients, as well.]

No comments: